COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population

The Bacillus Calmette–Guérin (BCG) is a well-known vaccine with almost a century of use, with the apparent capability to improve cytokine production and epigenetics changes that could develop a better response to pathogens. It has been postulated that BCG protection against SARS-CoV-2 has a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Garzon-Chavez, Daniel, Rivas-Condo, Jackson, Echeverria, Adriana, Mozo, Jhoanna, Quentin, Emmanuelle, Reyes, Jorge, Teran, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912416/
https://www.ncbi.nlm.nih.gov/pubmed/33513693
http://dx.doi.org/10.3390/vaccines9020091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912416/
https://www.ncbi.nlm.nih.gov/pubmed/33513693
http://dx.doi.org/10.3390/vaccines9020091

Ejemplares similares